Sernova Biotherapeutics (FRA:PSH0) COGS-to-Revenue : 0.00 (As of Jan. 2025)

View and export this data going back to 2014. Start your Free Trial

What is Sernova Biotherapeutics COGS-to-Revenue?

Sernova Biotherapeutics's Cost of Goods Sold for the three months ended in Jan. 2025 was €0.00 Mil. Its Revenue for the three months ended in Jan. 2025 was €0.00 Mil.

Sernova Biotherapeutics's COGS to Revenue for the three months ended in Jan. 2025 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Sernova Biotherapeutics's Gross Margin % for the three months ended in Jan. 2025 was N/A%.

Sernova Biotherapeutics COGS-to-Revenue Historical Data

The historical data trend for Sernova Biotherapeutics's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sernova Biotherapeutics COGS-to-Revenue Chart

Sernova Biotherapeutics Annual Data

Trend

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Oct24

COGS-to-Revenue

Get a 7-Day Free Trial

Sernova Biotherapeutics Quarterly Data
	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25
COGS-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	-

Sernova Biotherapeutics COGS-to-Revenue Calculation

Sernova Biotherapeutics's COGS to Revenue for the fiscal year that ended in Oct. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

Sernova Biotherapeutics's COGS to Revenue for the quarter that ended in Jan. 2025 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

Sernova Biotherapeutics (FRA:PSH0) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Sernova Biotherapeutics's Gross Margin % for the three months ended in Jan. 2025 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0 / 0
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Sernova Biotherapeutics COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Sernova Biotherapeutics's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Sernova Biotherapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sernova Biotherapeutics Inc (FRA:PSH0) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

SEOVF:USA PSH0:Germany SVA:Canada

Address

700 Collip Circle, Suite 114, London, ON, CAN, N6G 4X8

Website

https://www.sernova.com

Sernova Biotherapeutics Inc is a clinical-stage company developing regenerative medicines. The company develops Cell Pouch with human donor cells or stem cells to create a biohybrid organ. The Cell Pouch is a implantable medical device designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells, which then release proteins, hormones, or other factors into the bloodstream for the long-term treatment of multiple chronic diseases such as type 1 diabetes, hypothyroid disease, and rare diseases such as hemophilia A.

Sernova Biotherapeutics Headlines

No Headlines